SOX2 and ovarian carcinoma: Kim et al. [220] demonstrated that CD166 exhibited CSC-like properties in primary epithelial ovarian cancer cells and promoted the expression of CSC markers, including OCT4, SOX2, and ALDH1A1, as well as ABC transporters.